BURLINGTON, Mass. & NEW YORK / Nov 17, 2025 / Business Wire / Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care through innovative digital technologies for whole-body ultrasound imaging, today launched Compass AI™ – the latest generation of its enterprise software platform, powered by artificial intelligence (AI) to reduce workflow friction and support scalable, revenue-ready point-of-care ultrasound (POCUS) programs for health systems.
Most POCUS programs still use radiology-style, order-based workflows, which result in delays in documentation or orders being skipped altogether — leaving many exams undocumented, unreviewed, or unreimbursed. Compass AI replaces that with an AI-enhanced, encounter-based workflow built for POCUS, enabling documentation compliance rates of up to 94% without adding work for clinicians.1 Traditional workflows capture only about 15% of compliant studies, meaning up to 85% go unbilled; Compass AI can help translate that into as much as five times more revenue from the same clinical volume.1,2,3
Beyond documentation, Compass AI works across departments and ultrasound devices, turning POCUS from a set of siloed tools into a coordinated imaging service. It gives health systems the visibility and governance needed to scale, allowing administrators to track usage, credentialing, quality, and potential ROI — strengthening profitability, compliance, and care quality in real time. Key features* of Compass AI™ include:
“Health systems want to expand POCUS and capture more value, but they’ve been held back by undocumented exams, compliance risk and administrative burden that take clinicians away from patients,” said Joseph DeVivo, President, CEO and Chairman of Butterfly Network. “Compass AI changes that. It gives organizations the workflows and interoperability to manage POCUS programs at scale — no blind spots, no fragmented care, no added risk. To me, it’s a path to easy money: capturing value that was already there, just being missed.”
Compass AI is available starting today. To learn more or schedule a demonstration, visit www.butterflynetwork.com/compassai.
About Butterfly Network
Butterfly Network, Inc. (NYSE: BFLY) is a healthcare company driving a digital revolution in medical imaging with its proprietary Ultrasound-on-Chip™ semiconductor technology and ultrasound software solutions. In 2018, Butterfly launched the world’s first handheld, single-probe, whole-body ultrasound system, Butterfly iQ. The iQ+ followed in 2020, and the iQ3 in 2024, each with improved processing power and performance by leveraging Moore’s Law. The iQ3 earned Best Medical Technology at the 2024 Prix Galien USA Awards, a prestigious honor and one of the highest accolades in healthcare. Butterfly’s innovations have also been recognized by Fierce 50, TIME’s Best Inventions and Fast Company’s World Changing Ideas, among other achievements.
Butterfly combines advanced hardware, intelligent software, AI, services, and education to drive adoption of affordable, accessible imaging. Clinical publications demonstrate that its handheld ultrasound probes paired with Compass™ enterprise workflow software, can help hospital systems improve care workflows, reduce costs, and enhance provider economics. With a cloud-based solution that enables care anywhere through next-generation mobility, Butterfly aims to democratize healthcare by addressing critical global healthcare challenges. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit: https://www.butterflynetwork.com/choose-your-country.
Footnotes:
1 Rong K, Chimileski B, Kaloudis P, Herbst MK. Impact of an epic-integrated point-of-care ultrasound workflow on ultrasound performance, compliance, and potential revenue. Am J Emerg Med. 2021;49:233-239. doi:10.1016/j.ajem.2021.06.009
2 Riscinti M. System-Wide Point-of-Care Ultrasound: A Novel Encounter-Based-Workflow Across a Safety-Net Academic Health System - ACEP Industry Round Table.
3 Dhamija A, Perry L, Regan J, O'Connor T, Ulland L, Slavik E, Towbin A. (2023). Development and Implementation of a Semi-Automated Workflow for Point-of-Care Ultrasound Billing and Documentation Within an Electronic Health Record. Cureus, 15(3), e36417.
*Feature availability varies by region; not all features are available in all countries.

| Last Trade: | US$1.95 |
| Daily Change: | -0.17 -8.02 |
| Daily Volume: | 5,818,163 |
| Market Cap: | US$441.050M |
October 31, 2025 August 19, 2025 August 05, 2025 | |

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load